GORMAN-RUPP REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
Mansfield, Ohio – February 6, 2026 – The Gorman-Rupp Company (NYSE: GRC) reports financial results for the fourth quarter and year ended December 31, 2025.
Fourth Quarter 2025 Highlights
Net sales for the fourth quarter of 2025 were $166.6 million compared to net sales of $162.7 million for the fourth quarter of 2024, an increase of 2.4% or $3.9 million. Sales increased in the majority of our markets, including an increase of $2.8 million in the fire suppression market, $2.2 million in the industrial market, and $1.9 million in the OEM market all due in part to increased demand related to data centers. Sales also increased $2.6 million in the agriculture market and $0.8 million in the repair market. These increases were partially offset by sales decreases of $4.0 million in the municipal market due to the timing of domestic flood control and wastewater projects. Sales also decreased $2.2 million in the construction market primarily due to lower sales into the rental market, and decreased $0.2 million in the petroleum market.
Gross profit was $52.3 million for the fourth quarter of 2025, resulting in gross margin of 31.4%, compared to gross profit of $49.2 million and gross margin of 30.2% for the same period in 2024. The 120 basis point increase in gross margin was driven by a 110 basis point improvement in labor and overhead leverage, due in part to an unusual increase in healthcare related costs in the prior year which did not recur, and a 10 basis point improvement in cost of material driven by a reduction in LIFO2 expense.
Selling, general and administrative (“SG&A”) expenses were $24.4 million and 14.7% of net sales for the fourth quarter of 2025 compared to $25.0 million and 15.4% of net sales for the same period in 2024. SG&A expenses decreased in part due to an unusual increase in healthcare related costs in the prior year which did not recur.
Operating income was $24.8 million for the fourth quarter of 2025, resulting in an operating margin of 14.9%, compared to operating income of $21.1 million and an operating margin of 13.0% for the same period in 2024. The 190 basis point increase in operating margin, compared to the same period in 2024, was driven by improved leverage on labor, overhead, and SG&A expenses due to increased sales and reduced healthcare costs.
Interest expense was $5.4 million for the fourth quarter of 2025 compared to $6.7 million for the same period in 2024. The decrease in interest expense was due primarily to a decrease in outstanding debt.
Other income (expense), net was $1.5 million of expense for the fourth quarter of 2025 compared to $0.7 million of expense for the same period in 2024. Other expense for the fourth quarter of 2025 included non-cash pension settlement charges of $1.2 million.
Net income was $13.7 million, or $0.52 per share, for the fourth quarter of 2025 compared to net income of $11.0 million, or $0.42 per share, in the fourth quarter of 2024. Adjusted earnings per share1 for the fourth quarter of 2025 and 2024 were $0.55 and $0.42 per share, respectively.
Adjusted EBITDA1 was $31.5 million and 18.9% of sales for the fourth quarter of 2025 compared to $29.0 million and 17.8% of sales for the fourth quarter of 2024.
